RSSCategory: Community

Malaysia’s first public-private child care centre opens in Penang

November 25, 2022
Malaysia’s first public-private child care centre opens in Penang

A new public-private child care centre is set to open in Batu Kawan, Penang, in December 2022, borne of a joint partnership between Micron Technology, an industry leader in innovative memory and storage solutions, the Penang State Government and TalentCorp. […]

Continue Reading

FDA approves artificial meat for human consumption

November 21, 2022
FDA approves artificial meat for human consumption

US regulators have just approved the culture and use of meat made from animal cells – the US Food & Drug Administration (FDA) have deemed the meat product safe for humans to eat. The lab-grown invention was developed by Upside […]

Continue Reading

100 million Covid vaccine shots destroyed in India

November 7, 2022
100 million Covid vaccine shots destroyed in Indi

The Serum Institute of India (SII) has decided to dump 100 million doses of their now-expired COVID-19 vaccine. SII, the world’s largest vaccine maker, stopped producing the locally-administered Covishield vaccine in December last year due to low demand. “… people […]

Continue Reading

Survey finds financial burdens hinder the treatment of psoriasis

November 2, 2022
Survey finds financial burdens hinder the treatment of psoriasis

Many Malaysians suffering from psoriasis have said financial woes due to treatment costs influences their adherence to treatment, according to an international joint survey on psoriasis patients in South Korea, Hong Kong, and Malaysia known as the “Psoriasis Patient Access […]

Continue Reading

Sunway Sanctuary upscale senior living facility to open in 2023 in Kuala Lumpur

October 31, 2022

Sunway Healthcare Group (Sunway Healthcare) is set to launch its flagship senior living residence in response to increasing demand for an exclusive and opulent senior living community in the Klang Valley. Sunway Sanctuary is a meticulously designed township with accessibility […]

Continue Reading

Measles cases surge in Africa, worldwide, post-COVID

October 25, 2022
Measles cases surge in Africa, worldwide, post-COVID

Hospitals in remote parts of Africa and more ran out of measles vaccines during the frenzy of the COVID-19 pandemic, leaving millions of children unprotected against one of the world’s most contagious diseases. The World Health Organization (WHO) revealed that […]

Continue Reading

Sunway Medical Centre holds symposium for common eye conditions

October 24, 2022
Sunway Medical Centre holds symposium for common eye conditions

While we often assume that a slight discomfort in the eye is something that will come and go, in fact, those tiny pair of monogram balls are more likely informing us about the condition of our eye health. In conjunction […]

Continue Reading

Cataracts and presbyopia correction with Alcon

October 17, 2022
Cataracts and presbyopia correction with Alcon

Cataracts and presbyopia correction with Alcon. HCA Facebook Cataracts and presbyopia correction with Alcon Cataracts and presbyopia correction with Alcon Eyecare specialists at Alcon have conducted a media workshop to educate Malaysians about sight-robbing eye conditions and how best to […]

Continue Reading

WHO, ECDC warm of oncoming COVID wave in Europe

October 13, 2022
WHO, ECDC warm of oncoming COVID wave in Europe

The World Health Organization and the European Centre for Disease Prevention and Control (ECDC) have announced that Europe is likely entering yet another COVID wave, noting an uptick in cases across the region. Despite the COVID pandemic falling on the […]

Continue Reading

MSD launches new manufacturing facilities in Singapore

October 7, 2022
MSD (trade name of Merck & Co., Inc.) has opened a new secondary packaging facility in Singapore, the home of MSD’s Asia Pacific hub. The secondary packaging facility is expected to support the production of vaccines and biologics, including the company’s cancer immunotherapy products. MSD also broke ground for a new inhaler production facility for the manufacture of new generation inhaler medicines in Singapore. Both manufacturing facilities are key components of the company’s up to US$500 million investment over five years that started in 2020 – in addition to the US$2 billion invested since the start of MSD’s manufacturing operations in Singapore in 1997. Other components of the US$500 million investment include incorporation of new technology to further MSD’s environmental sustainability goals, and modernisation of MSD’s information technology (IT) infrastructure in support of digitising the facilities. The opening of the new secondary packaging facility and ground-breaking for the inhaler production facility was witnessed by Singapore’s Minister for Trade & Industry and Guest-of-Honour, Gan Kim Yong, and Robert Davis, CEO and President of MSD. The new facilities are located within MSD’s existing 72-acre, multi-product manufacturing hub in Tuas. The secondary packaging facility will house a semi-automated, vial-packaging line to produce immunotherapy drug Keytruda (pembrolizumab), and three fully automated syringe-packaging lines to produce the company’s HPV recombinant vaccine, Gardasil. In 2021, the site commenced the sterile filling process of the immunotherapy drug vials. Secondary packaging, cold storage, and a quality control laboratory will be a part of the expanded facility which further adds to the supply chain footprint for this product in Singapore. Meanwhile, the new inhaler medicine facility, when ready in 2026, will manufacture next generation inhaler devices for targeted administration of medicines. “MSD is committed to Singapore as a strategic node in our company’s global manufacturing network with a focus on producing innovative medicines to treat chronic diseases and cancer as well as vaccines that prevent infectious diseases for patients living in Singapore and throughout the Asia Pacific region and beyond,” said Fernando Otero, Associate VP, MSD Manufacturing Division, Singapore. “The talent, research, and technology capabilities that first attracted our company to Singapore has been a key incentive for our continuing investment. We’re delighted to further invest in building technologically advanced facilities and highly skilled manufacturing here,” he added. The multi-year investment plan is estimated to create over 100 new jobs over the next few years to support the new facility, with many positions requiring advanced manufacturing and digital skills. This would bring the company’s total employees in Singapore to more than 1,800 over the next few years. In a closing note, David Peacock, President, Asia Pacific, MSD, said, “MSD has been in Singapore since 1993 and continues to invest significantly in Singapore to impact patients worldwide through our innovative medicines and vaccines. “The launch of the new secondary packaging facility and ground-breaking for the new inhaler facility today highlights the value that biopharmaceutical innovation brings to Singapore, contributing to the health and wellbeing of the nation and the region. It further demonstrates our commitment to making a difference by bringing our medicines and vaccines to people as quickly as possible, while ensuring that the Asia Pacific region is well-positioned to manage future healthcare challenges.”

MSD (trade name of Merck & Co., Inc.) has opened a new secondary packaging facility in Singapore, the home of MSD’s Asia Pacific hub. The secondary packaging facility is expected to support the production of vaccines and biologics, including the […]

Continue Reading